As more people with amputations choose osseointegration (OI), prosthetists across the country are learning how to support this patient base.
About 2,000 patients across the world have undergone the procedure to have titanium implanted inside their bones to connect to their prostheses. About 500 of those patients have received the Osseo anchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System, the only US Food and Drug (FDA)-Approved osseointegration solution in the United States.
Dr. Jason Stoneback calls osseointegration (OI) a “game-changer” for amputees. He also knows that successful outcomes can’t be assumed. They have to be earned.
Osseointegration, a form of implant surgery, is restoring freedom of movement to amputees in a revolutionary new way. Correspondent Barry Petersen speaks to doctors about this prosthetic procedure, and with patients who are embracing their expanded mobility with a vengeance.
In December 2020, the FDA approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System—the first implant system in the United States for transfemoral amputees who have difficulty using a conventional prosthesis. OPRA had been previously available and marketed under a humanitarian device exemption (HDE) since 2015.
Momentum 2017 celebrates the power and impact of philanthropy at the University of Colorado Anschutz Medical Campus. These stories detail philanthropy in action – transforming health and health care.
The Army parachutist had jumped out of airplanes at night, done three tours in Afghanistan, one in Kuwait and served in Korea and Colombia. Despite all the danger he faced, Jandl, now 41, never suffered a scratch overseas.